| NP0341913 | chamilactone D | |  | C15H16O4
260.2890 Da 260.10486 Da | | [1H, 13C] NMR Spectrum (2D, 600 MHz, C2D6OS, experimental) | | 13C NMR Spectrum (1D, 151 MHz, C2D6OS, experimental) | | [1H, 1H] NMR Spectrum (2D, 600 MHz, C2D6OS, experimental) | | [1H, 13C] NMR Spectrum (2D, 600 MHz, C2D6OS, experimental) | | 1H NMR Spectrum (1D, 600 MHz, C2D6OS, experimental) |
|
| NP0341912 | chamilactone C | |  | C15H18O3
246.3060 Da 246.12559 Da | | [1H, 13C] NMR Spectrum (2D, 600 MHz, C2D6OS, experimental) | | 1H NMR Spectrum (1D, 600 MHz, C2D6OS, experimental) | | [1H, 13C] NMR Spectrum (2D, 600 MHz, C2D6OS, experimental) | | 13C NMR Spectrum (1D, 151 MHz, C2D6OS, experimental) |
|
| NP0341911 | chamilactone B | |  | C14H14O5
262.2610 Da 262.08412 Da | | [1H, 1H] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) | | 1H NMR Spectrum (1D, 600 MHz, CDCl3, experimental) | | [1H, 13C] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) | | [1H, 1H] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) | | [1H, 13C] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) | | 13C NMR Spectrum (1D, 151 MHz, CDCl3, experimental) |
|
| NP0341910 | chamilactone A | |  | C14H14O5
262.2610 Da 262.08412 Da | | 13C NMR Spectrum (1D, 126 MHz, CDCl3, experimental) | | [1H, 1H] NMR Spectrum (2D, 500 MHz, CDCl3, experimental) | | [1H, 13C] NMR Spectrum (2D, 500 MHz, CDCl3, experimental) | | [1H, 13C] NMR Spectrum (2D, 500 MHz, CDCl3, experimental) | | [1H, 1H] NMR Spectrum (2D, 500 MHz, CDCl3, experimental) | | 1H NMR Spectrum (1D, 500 MHz, CDCl3, experimental) |
|
| NP0341909 | 5α,9α,10β,13α-tetraacetoxy-15-hydroxy- 11(15->1)abeo-texa-(20),11-diene | |  | C28H40O9
520.6190 Da 520.26723 Da | | [1H, 1H] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) | | [1H, 1H] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) | | 13C NMR Spectrum (1D, 151 MHz, CDCl3, experimental) | | [1H, 1H] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) | | [1H, 13C] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) | | [1H, 13C] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) | | 1H NMR Spectrum (1D, 600 MHz, CDCl3, experimental) | | [1H, 13C] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) | | 1H NMR Spectrum (1D, 600 MHz, CDCl3, experimental) |
|
| NP0341908 | 1β-hydroxytaxusin | |  | C28H40O9
520.6190 Da 520.26723 Da | | 1H NMR Spectrum (1D, 600 MHz, CDCl3, experimental) | | [1H, 1H] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) | | [1H, 1H] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) | | 13C NMR Spectrum (1D, 151 MHz, CDCl3, experimental) | | [1H, 13C] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) | | [1H, 13C] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) |
|
| NP0341907 | 13β-taxusin | |  | C28H40O8
504.6200 Da 504.27232 Da | | [1H, 13C] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) | | [1H, 13C] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) | | [1H, 1H] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) | | 1H NMR Spectrum (1D, 600 MHz, CDCl3, experimental) | | [1H, 1H] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) | | [1H, 1H] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) | | 13C NMR Spectrum (1D, 151 MHz, CDCl3, experimental) | | 1H NMR Spectrum (1D, 600 MHz, CDCl3, experimental) |
|
| NP0341906 | taxusin | |  | C28H40O8
504.6200 Da 504.27232 Da | | 13C NMR Spectrum (1D, 25 MHz, D2O, predicted) | | 1H NMR Spectrum (1D, 100 MHz, D2O, predicted) | | 13C NMR Spectrum (1D, 252 MHz, D2O, predicted) | | 1H NMR Spectrum (1D, 1000 MHz, D2O, predicted) | | 13C NMR Spectrum (1D, 50 MHz, D2O, predicted) | | 1H NMR Spectrum (1D, 200 MHz, D2O, predicted) | | 13C NMR Spectrum (1D, 75 MHz, D2O, predicted) | | 1H NMR Spectrum (1D, 300 MHz, D2O, predicted) | | 13C NMR Spectrum (1D, 101 MHz, D2O, predicted) | | 1H NMR Spectrum (1D, 400 MHz, D2O, predicted) | | 13C NMR Spectrum (1D, 126 MHz, D2O, predicted) | | 1H NMR Spectrum (1D, 500 MHz, D2O, predicted) | | 13C NMR Spectrum (1D, 151 MHz, D2O, predicted) | | 1H NMR Spectrum (1D, 600 MHz, D2O, predicted) | | 13C NMR Spectrum (1D, 176 MHz, D2O, predicted) | | 1H NMR Spectrum (1D, 700 MHz, D2O, predicted) | | 13C NMR Spectrum (1D, 201 MHz, D2O, predicted) | | 1H NMR Spectrum (1D, 800 MHz, D2O, predicted) | | 13C NMR Spectrum (1D, 226 MHz, D2O, predicted) | | 1H NMR Spectrum (1D, 900 MHz, D2O, predicted) |
|
| NP0341905 | (+)-8-acetylarteminolide | |  | C32H36O8
548.6320 Da 548.24102 Da | | 1H NMR Spectrum (1D, 500 MHz, CD3OD, experimental) | | 13C NMR Spectrum (1D, 126 MHz, CD3OD, experimental) | | 13C NMR Spectrum (1D, 126 MHz, CD3OD, experimental) | | [1H, 1H] NMR Spectrum (2D, 500 MHz, CD3OD, experimental) | | [1H, 13C] NMR Spectrum (2D, 500 MHz, CD3OD, experimental) | | [1H, 13C] NMR Spectrum (2D, 500 MHz, CD3OD, experimental) | | [1H, 1H] NMR Spectrum (2D, 500 MHz, CD3OD, experimental) |
|
| NP0341904 | argyinolide O | |  | C30H34O6
490.5960 Da 490.23554 Da | | 1H NMR Spectrum (1D, 500 MHz, CD3OD, experimental) | | 13C NMR Spectrum (1D, 126 MHz, CD3OD, experimental) | | 13C NMR Spectrum (1D, 126 MHz, CD3OD, experimental) | | [1H, 1H] NMR Spectrum (2D, 500 MHz, CD3OD, experimental) | | [1H, 13C] NMR Spectrum (2D, 500 MHz, CD3OD, experimental) | | [1H, 13C] NMR Spectrum (2D, 500 MHz, CD3OD, experimental) | | [1H, 1H] NMR Spectrum (2D, 500 MHz, CD3OD, experimental) |
|
| NP0341903 | 7-en-13-hytanaphallin | |  | C15H18O5
278.3040 Da 278.11542 Da | | 1H NMR Spectrum (1D, 500 MHz, CD3OD, experimental) | | 13C NMR Spectrum (1D, 126 MHz, CD3OD, experimental) | | 13C NMR Spectrum (1D, 126 MHz, CD3OD, experimental) | | [1H, 1H] NMR Spectrum (2D, 500 MHz, CD3OD, experimental) | | [1H, 13C] NMR Spectrum (2D, 500 MHz, CD3OD, experimental) | | [1H, 13C] NMR Spectrum (2D, 500 MHz, CD3OD, experimental) | | [1H, 13C] NMR Spectrum (2D, 500 MHz, CD3OD, experimental) | | [1H, 1H] NMR Spectrum (2D, 500 MHz, CD3OD, experimental) |
|
| NP0341902 | 8´-en-achillinin | |  | C30H34O8
522.5940 Da 522.22537 Da | | 1H NMR Spectrum (1D, 500 MHz, CD3OD, experimental) | | 13C NMR Spectrum (1D, 126 MHz, CD3OD, experimental) | | 13C NMR Spectrum (1D, 126 MHz, CD3OD, experimental) | | [1H, 1H] NMR Spectrum (2D, 500 MHz, CD3OD, experimental) | | [1H, 13C] NMR Spectrum (2D, 500 MHz, CD3OD, experimental) | | [1H, 13C] NMR Spectrum (2D, 500 MHz, CD3OD, experimental) | | [1H, 1H] NMR Spectrum (2D, 500 MHz, CD3OD, experimental) |
|
| NP0341901 | Norsuberitenone B | |  | C20H32O3
320.4730 Da 320.23514 Da | | 13C NMR Spectrum (1D, 101 MHz, CDCl3, experimental) | | [1H, 1H] NMR Spectrum (2D, 400 MHz, CDCl3, experimental) | | [1H, 13C] NMR Spectrum (2D, 400 MHz, CDCl3, experimental) | | [1H, 1H] NMR Spectrum (2D, 400 MHz, CDCl3, experimental) | | 1H NMR Spectrum (1D, 400 MHz, CDCl3, experimental) | | [1H, 13C] NMR Spectrum (2D, 500 MHz, CDCl3, experimental) |
|
| NP0341900 | Furanosuberitandiol | |  | C27H36O6
456.5790 Da 456.25119 Da | | 13C NMR Spectrum (1D, 101 MHz, CDCl3, experimental) | | 1H NMR Spectrum (1D, 600 MHz, CDCl3, experimental) | | [1H, 1H] NMR Spectrum (2D, 400 MHz, CDCl3, experimental) | | [1H, 13C] NMR Spectrum (2D, 400 MHz, CDCl3, experimental) | | [1H, 13C] NMR Spectrum (2D, 400 MHz, CDCl3, experimental) | | [1H, 1H] NMR Spectrum (2D, 400 MHz, CDCl3, experimental) |
|
| NP0341899 | Abeosuberitandiol | |  | C27H38O5
442.5960 Da 442.27192 Da | | 13C NMR Spectrum (1D, 101 MHz, CDCl3, experimental) | | 1H NMR Spectrum (1D, 400 MHz, CDCl3, experimental) | | [1H, 1H] NMR Spectrum (2D, 400 MHz, CDCl3, experimental) | | [1H, 13C] NMR Spectrum (2D, 400 MHz, CDCl3, experimental) | | [1H, 13C] NMR Spectrum (2D, 400 MHz, CDCl3, experimental) | | [1H, 1H] NMR Spectrum (2D, 400 MHz, CDCl3, experimental) |
|
| NP0341898 | Suberitandiol | |  | C27H40O4
428.6130 Da 428.29266 Da | | 13C NMR Spectrum (1D, 101 MHz, CDCl3, experimental) | | 1H NMR Spectrum (1D, 400 MHz, CDCl3, experimental) | | [1H, 1H] NMR Spectrum (2D, 400 MHz, CDCl3, experimental) | | [1H, 13C] NMR Spectrum (2D, 400 MHz, CDCl3, experimental) | | [1H, 13C] NMR Spectrum (2D, 400 MHz, CDCl3, experimental) | | [1H, 1H] NMR Spectrum (2D, 400 MHz, CDCl3, experimental) |
|
| NP0341897 | Suberitenone K | |  | C27H38O5
442.5960 Da 442.27192 Da | | 13C NMR Spectrum (1D, 101 MHz, CD3OD, experimental) | | 1H NMR Spectrum (1D, 400 MHz, CD3OD, experimental) | | [1H, 1H] NMR Spectrum (2D, 600 MHz, CD3OD, experimental) | | [1H, 13C] NMR Spectrum (2D, 600 MHz, CD3OD, experimental) | | [1H, 1H] NMR Spectrum (2D, 400 MHz, CD3OD, experimental) | | [1H, 13C] NMR Spectrum (2D, 500 MHz, CD3OD, experimental) |
|
| NP0341896 | Indanopyrrole B | |  | C22H27Cl2NO3
424.3600 Da 423.13680 Da | | 1H NMR Spectrum (1D, 600 MHz, CD3OD, experimental) | | [1H, 1H] NMR Spectrum (2D, 600 MHz, CD3OD, experimental) | | [1H, 13C] NMR Spectrum (2D, 600 MHz, CD3OD, experimental) | | [1H, 13C] NMR Spectrum (2D, 600 MHz, CD3OD, experimental) |
|
| NP0341895 | Indanopyrrole A | |  | C22H26Cl3NO3
458.8000 Da 457.09783 Da | | [1H, 1H] NMR Spectrum (2D, 500 MHz, CD3OD, experimental) | | [1H, 13C] NMR Spectrum (2D, 126 MHz, CD3OD, experimental) | | [1H, 1H] NMR Spectrum (2D, 500 MHz, CD3OD, experimental) | | [1H, 13C] NMR Spectrum (2D, 126 MHz, CD3OD, experimental) |
|
| NP0341894 | 4´-O-β-glucopyranosyl- allomethylosyl 12-deoxy aspecioside | |  | C35H52O14
696.7870 Da 696.33571 Da | | 1H NMR Spectrum (1D, 800 MHz, CD3OD, experimental) | | [1H, 1H] NMR Spectrum (2D, 800 MHz, CD3OD, experimental) | | [1H, 13C] NMR Spectrum (2D, 800 MHz, CD3OD, experimental) | | [1H, 13C] NMR Spectrum (2D, 800 MHz, CD3OD, experimental) | | [1H, 1H] NMR Spectrum (2D, 800 MHz, CD3OD, experimental) |
|
| NP0341893 | 4´-O-β- glucopyranosyl allomethylosyl syriogenin | |  | C35H54O14
698.8030 Da 698.35136 Da | | 13C NMR Spectrum (1D, 151 MHz, CD3OD, experimental) | | 1H NMR Spectrum (1D, 800 MHz, CD3OD, experimental) | | [1H, 1H] NMR Spectrum (2D, 800 MHz, CD3OD, experimental) | | [1H, 13C] NMR Spectrum (2D, 800 MHz, CD3OD, experimental) | | [1H, 13C] NMR Spectrum (2D, 800 MHz, CD3OD, experimental) | | [1H, 1H] NMR Spectrum (2D, 800 MHz, CD3OD, experimental) |
|
| NP0341892 | C-3' epi-syrioside | |  | C35H48O16
724.7530 Da 724.29424 Da | | 13C NMR Spectrum (1D, 151 MHz, CD3OD, experimental) | | 1H NMR Spectrum (1D, 800 MHz, CD3OD, experimental) | | [1H, 1H] NMR Spectrum (2D, 800 MHz, CD3OD, experimental) | | [1H, 13C] NMR Spectrum (2D, 800 MHz, CD3OD, experimental) | | [1H, 13C] NMR Spectrum (2D, 800 MHz, CD3OD, experimental) | | [1H, 1H] NMR Spectrum (2D, 800 MHz, CD3OD, experimental) |
|
| NP0341891 | .3´-O-β- glucopyranosyl syribioside | |  | C35H50O16
726.7690 Da 726.30989 Da | | 13C NMR Spectrum (1D, 151 MHz, CD3OD, experimental) | | 1H NMR Spectrum (1D, 800 MHz, CD3OD, experimental) | | [1H, 1H] NMR Spectrum (2D, 800 MHz, CD3OD, experimental) | | [1H, 13C] NMR Spectrum (2D, 800 MHz, CD3OD, experimental) | | [1H, 13C] NMR Spectrum (2D, 800 MHz, CD3OD, experimental) | | [1H, 1H] NMR Spectrum (2D, 800 MHz, CD3OD, experimental) |
|
| NP0341890 | 4´-O-β-glucopyranosyl aspecioside | |  | C35H52O15
712.7860 Da 712.33062 Da | | 13C NMR Spectrum (1D, 151 MHz, CD3OD, experimental) | | 1H NMR Spectrum (1D, 800 MHz, CD3OD, experimental) | | [1H, 1H] NMR Spectrum (2D, 800 MHz, CD3OD, experimental) | | [1H, 13C] NMR Spectrum (2D, 800 MHz, CD3OD, experimental) | | [1H, 13C] NMR Spectrum (2D, 800 MHz, CD3OD, experimental) | | [1H, 1H] NMR Spectrum (2D, 800 MHz, CD3OD, experimental) |
|
| NP0341889 | 13-carboxyintegric acid | |  | C25H32O7
444.5240 Da 444.21480 Da | |